|
|
Neurocognitive implications of cannabidiol (CBD) while aging with HIV |
| 1R03DA057146-01 |
|
NIDA |
2022 |
|
|
Leveraging ΔFosB as a potential therapeutic for Alzheimers Disease |
| 3R01DA040621-07S1 |
|
NIDA |
2022 |
|
|
Neuroepigenetic mechanisms of chronic low back pain using histone deacetylases PET imaging |
| 4R33DA048485-03 |
|
NIDA |
2022 |
|
|
CAR-based approaches for the treatment of Alzheimers Disease |
| 1DP5OD033428-01 |
|
OD |
2022 |
|
|
Sex chromosomal regulation of hippocampal microglial activation with Alzheimers disease and aging |
| 1DP5OD033443-01 |
|
OD |
2022 |
|
|
Imaging microglial activation in aged marmosets |
| 3P51OD011133-24S1 |
|
OD |
2022 |
|
|
Explore the APOE e4-mediated p53 activation in Alzheimers Disease |
| 3R01OD026594-04S1 |
|
OD |
2022 |
|
|
Targeted Immunotherapy in a Nonhuman Primate Model of Alzheimers Disease |
| 3R24OD028257-03S1 |
|
OD |
2022 |
|
|
TRiP resources for modeling human disease |
| 3R24OD030002-03S1 |
|
OD |
2022 |
|
|
Revealing tissue microstructure in the brain gray matter in Alzheimers disease using in vivo high-gradient diffusion MRI |
| 5DP5OD031854-02 |
|
OD |
2022 |